In a 2-year randomized clinical trial a moderate-fat, restricted-energy, MedDiet in subjects with obesity resulted in greater body weight reduction and lower alanine aminotransferase (ALT) levels compared to low-fat restricted-energy diet. The gene discussed is GPT; the disease is obesity due to melanocortin 4 receptor deficiency.